Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice
Stem cells have opened a new avenue to treat liver fibrosis. We investigated in vitro and in vivo the effect of cytokine (HGF and FGF4) pretreated MSCs in reduction of CCl4 liver injury. Mouse MSCs were pretreated with cytokines to improve their ability to reduce CCl4 injury. In vitro we gave CCl4 i...
Saved in:
Main Authors: | Sulaiman Shams, Sadia Mohsin, Ghazanfar Ali Nasir, Mohsin Khan, Shaheen N. Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/747245 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure
by: Yunxia Tang, et al.
Published: (2016-01-01) -
Stem Cells and Cardiac Repair
by: Sadia Mohsin, et al.
Published: (2015-01-01) -
Estradiol-dependent and independent effects of FGF21 in obese female mice
by: T. V. Jakovleva, et al.
Published: (2022-04-01) -
Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
by: Jingjing You, et al.
Published: (2015-01-01) -
Clostridium Scindens Protects Against Vancomycin‐Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR‐FGF15/19 Signaling
by: Jintao Xiao, et al.
Published: (2025-02-01)